Alterity Therapeutics Limited (ATHE)
NASDAQ: ATHE · Real-Time Price · USD
4.665
0.00 (0.00%)
Jul 28, 2026, 10:55 AM EDT - Market open
Alterity Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Alterity Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $12.67. The average 1-year stock price forecast is 171.60% higher than the current stock price, while the lowest is $10 (+114.36%) and the highest is $16 (+242.98%).
Price Target: $12.67 (+171.60%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Alterity Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 1 | 0 | 0 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 2 | 1 | 1 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JonesTrading | JonesTrading | Buy Maintains $16 | Buy | Maintains | $16 | +242.98% | Jul 8, 2026 |
| Ladenburg Thalmann & Co. | Ladenburg Thalmann & Co. | Buy Initiates $10 | Buy | Initiates | $10 | +114.36% | Jun 16, 2026 |
| Maxim Group | Maxim Group | Buy Reiterates $12 | Buy | Reiterates | $12 | +157.23% | Jun 10, 2026 |
Financial Forecast
Revenue This Year
2.65M
from 5.44M
Decreased by -51.33%
Revenue Next Year
1.24M
from 2.65M
Decreased by -53.27%
EPS This Year
-1.76
EPS Next Year
-1.77
from -1.76
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.